Abstract
Fifteen patients with beta-thalassemia received an allogeneic peripheral blood stem cell transplant. Median age was 3.5 years (1–15 years). Six were class I, four class II and five class III according to the Pesaro criteria. All of the donors were HLA-phenotypically identical (13 siblings and two parents). Nine patients were given BU + CY and six BU + CY plus ATG as conditioning. All patients received MTX (+1, +3, +6) and CsA (9–12 months) post transplant for GVHD prophylaxis. The median neutrophil and platelet engraftment times were day 12 and day 16, respectively. cGVHD was observed in three patients. Two patients died. Thirteen patients are well, and transfusion-independent 2–30 months after PSCT. No recurrences of thalassemia have been seen. Overall and event-free survival were 86.6%. In conclusion, we suggest that PSCT can be considered a safe and effective treatment for children with beta- thalassemia.
Bone Marrow Transplantation (2001) 28, 1037–1040.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Thomas ED, Buckner CD, Sanders JE et al. Marrow transplantation for thalassemia Lancet 1982 2: 227–228
Lucarelli G, Galimberti M, Giardini C et al. Bone marrow transplantation in thalassemia: the experience of Pesaro Ann NY Acad Sci 1998 850: 270–275
Lickliter JD, De For T, Wagner JE et al. Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation Blood 1998 92 (Suppl. 1): 561a
Ottinger HD, Beelen DW, Sheulen B et al. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow Blood 1996 88: 2775–2779
Diaz MA, Kanold J, Vicent MG et al. Using peripheral blood progenitor cells (PBPC) for transplantation in pediatric patients: a state-of-the-art review Bone Marrow Transplant 2000 26: 1291–1298
Lucarelli G, Galimberti M, Polchi P et al. Bone marrow transplantation in patients with thalassemia New Engl J Med 1990 332: 417–421
Devergie A, Ianin A . Graft-versus-host disease. In: Apperley JF, Gluckman E, Gratwohl A (eds). Bone Marrow Transplantation, EBMT Handbook. European School of Haematology, Revised Edition, Paris 2000 pp 134–151
Bircan I, Sisli S, Güven A et al. Hemoglobinopathies in the district of Antalya, Turkey Ped Hematol Oncol 1993 10: 289–291
Matsubara H, Makimoto A, Takayama J et al. Possible clinical benefits of the use of peripheral blood stem cells over bone marrow in the allogeneic transplantation setting for the treatment of childhood leukemia Jpn J Clin Oncol 2001 31: 30–34
Körbling M, Chan KW, Anderlini P et al. Allogenic peripheral blood stem cell transplantation using normal patient-related pediatric donors Bone Marrow Transplant 1996 18: 885–890
Levine JE, Wiley J, Kletzel M et al. Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD Bone Marrow Transplant 2000 25: 13–18
Li CK, Yuen PM, Chik KW et al. Allogeneic peripheral blood stem cell transplant in children Med Pediatr Oncol 1998 30: 147–151
Villa M, Madero L, Diaz MA et al. Allogeneic peripheral blood progenitor cell (PBPC) transplantation in children Bone Marrow Transplant 1996 18: 231–233
Miniero R, Busca A, Pession A et al. Allogeneic peripheral blood stem cell transplantation in children with hematologic malignancies Haematologica 1999 84: 657–660
Cavallaro AM, Lilleby K, Majolino I et al. Three to 6-year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor Bone Marrow Transplant 2000 25: 85–89
Kawano Y, Takaue Y, Watanabe T et al. Peripheral stem cell mobilisation with granulocyte colony-stimulating factor and a harvesting procedure in pediatric donors Bone Marrow Transplant 1998 21 (Suppl. 3): S32–S34
Watanabe T, Kawano Y, Watanabe A et al. Autologous and allogeneic transplantation in peripheral blood CD34+ cells: a pediatric experience Haematologica 1999 84: 167–176
Lucarelli G, Clift RA, Galimberti M et al. Marrow transplantation for patients with thalassemia. Results in class 3 patients Blood 1996 87: 2082–2088
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yesilipek, M., Hazar, V., Küpesiz, A. et al. Peripheral blood stem cell transplantation in children with beta-thalassemia. Bone Marrow Transplant 28, 1037–1040 (2001). https://doi.org/10.1038/sj.bmt.1703284
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703284
Keywords
This article is cited by
-
Thalassemia-free and graft-versus-host-free survival: outcomes of hematopoietic stem cell transplantation for thalassemia major, Turkish experience
Bone Marrow Transplantation (2022)
-
Bone marrow transplant cure for β-thalassaemia major: initial experience from a developing country
Annals of Hematology (2008)